nodes	percent_of_prediction	percent_of_DWPC	metapath
Irinotecan—CES2—E2F transcription factor network—WASF1—conduct disorder	0.0606	0.0606	CbGpPWpGaD
Irinotecan—ACHE—Neurotransmitter Clearance In The Synaptic Cleft—COMT—conduct disorder	0.058	0.058	CbGpPWpGaD
Irinotecan—ACHE—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—conduct disorder	0.0576	0.0576	CbGpPWpGaD
Irinotecan—BCHE—Neurotransmitter Clearance In The Synaptic Cleft—COMT—conduct disorder	0.0517	0.0517	CbGpPWpGaD
Irinotecan—BCHE—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—conduct disorder	0.0514	0.0514	CbGpPWpGaD
Irinotecan—CES1—E2F transcription factor network—WASF1—conduct disorder	0.0357	0.0357	CbGpPWpGaD
Irinotecan—ACHE—Biogenic Amine Synthesis—COMT—conduct disorder	0.0351	0.0351	CbGpPWpGaD
Irinotecan—ACHE—Biogenic Amine Synthesis—MAOA—conduct disorder	0.0348	0.0348	CbGpPWpGaD
Irinotecan—UGT1A1—Estrogen metabolism—COMT—conduct disorder	0.0288	0.0288	CbGpPWpGaD
Irinotecan—UGT1A9—Estrogen metabolism—COMT—conduct disorder	0.0288	0.0288	CbGpPWpGaD
Irinotecan—CES2—NRF2 pathway—SLC6A4—conduct disorder	0.0259	0.0259	CbGpPWpGaD
Irinotecan—ACHE—Monoamine Transport—SLC6A4—conduct disorder	0.0252	0.0252	CbGpPWpGaD
Irinotecan—TOP1—Circadian rythm related genes—SLC6A4—conduct disorder	0.0246	0.0246	CbGpPWpGaD
Irinotecan—TOP1—Circadian rythm related genes—DRD4—conduct disorder	0.0231	0.0231	CbGpPWpGaD
Irinotecan—SLC22A3—Synaptic Vesicle Pathway—SLC6A4—conduct disorder	0.0221	0.0221	CbGpPWpGaD
Irinotecan—ACHE—Melatonin metabolism and effects—MAOA—conduct disorder	0.0205	0.0205	CbGpPWpGaD
Irinotecan—ACHE—Peptide hormone metabolism—CGA—conduct disorder	0.0194	0.0194	CbGpPWpGaD
Irinotecan—BCHE—Peptide hormone metabolism—CGA—conduct disorder	0.0173	0.0173	CbGpPWpGaD
Irinotecan—CES1—NRF2 pathway—SLC6A4—conduct disorder	0.0152	0.0152	CbGpPWpGaD
Irinotecan—CES2—E2F transcription factor network—EP300—conduct disorder	0.0146	0.0146	CbGpPWpGaD
Irinotecan—ACHE—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00917	0.00917	CbGpPWpGaD
Irinotecan—CES1—E2F transcription factor network—EP300—conduct disorder	0.00862	0.00862	CbGpPWpGaD
Irinotecan—TOP1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.00831	0.00831	CbGpPWpGaD
Irinotecan—BCHE—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00818	0.00818	CbGpPWpGaD
Irinotecan—CYP3A4—Estrogen metabolism—COMT—conduct disorder	0.00813	0.00813	CbGpPWpGaD
Irinotecan—UGT1A1—Phase II conjugation—COMT—conduct disorder	0.00808	0.00808	CbGpPWpGaD
Irinotecan—UGT1A9—Phase II conjugation—COMT—conduct disorder	0.00808	0.00808	CbGpPWpGaD
Irinotecan—TOP1—Circadian rythm related genes—EP300—conduct disorder	0.00798	0.00798	CbGpPWpGaD
Irinotecan—CYP3A7—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00743	0.00743	CbGpPWpGaD
Irinotecan—UGT1A1—NRF2 pathway—SLC6A4—conduct disorder	0.00711	0.00711	CbGpPWpGaD
Irinotecan—UGT1A9—NRF2 pathway—SLC6A4—conduct disorder	0.00711	0.00711	CbGpPWpGaD
Irinotecan—ACHE—Neuronal System—GABRA2—conduct disorder	0.00703	0.00703	CbGpPWpGaD
Irinotecan—ABCC2—NRF2 pathway—SLC6A4—conduct disorder	0.00694	0.00694	CbGpPWpGaD
Irinotecan—ABCG2—HIF-2-alpha transcription factor network—EP300—conduct disorder	0.00629	0.00629	CbGpPWpGaD
Irinotecan—BCHE—Neuronal System—GABRA2—conduct disorder	0.00627	0.00627	CbGpPWpGaD
Irinotecan—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.00582	0.00582	CbGpPWpGaD
Irinotecan—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.00582	0.00582	CbGpPWpGaD
Irinotecan—CYP2B6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.0055	0.0055	CbGpPWpGaD
Irinotecan—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00537	0.00537	CbGpPWpGaD
Irinotecan—ACHE—ATF-2 transcription factor network—EP300—conduct disorder	0.00503	0.00503	CbGpPWpGaD
Irinotecan—SLC22A3—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.0048	0.0048	CbGpPWpGaD
Irinotecan—UGT1A1—Biological oxidations—COMT—conduct disorder	0.00473	0.00473	CbGpPWpGaD
Irinotecan—UGT1A9—Biological oxidations—COMT—conduct disorder	0.00473	0.00473	CbGpPWpGaD
Irinotecan—UGT1A1—Biological oxidations—MAOA—conduct disorder	0.00469	0.00469	CbGpPWpGaD
Irinotecan—UGT1A9—Biological oxidations—MAOA—conduct disorder	0.00469	0.00469	CbGpPWpGaD
Irinotecan—UGT1A1—Metapathway biotransformation—COMT—conduct disorder	0.00466	0.00466	CbGpPWpGaD
Irinotecan—UGT1A9—Metapathway biotransformation—COMT—conduct disorder	0.00466	0.00466	CbGpPWpGaD
Irinotecan—ACHE—Transmission across Chemical Synapses—COMT—conduct disorder	0.00442	0.00442	CbGpPWpGaD
Irinotecan—ACHE—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00438	0.00438	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00424	0.00424	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00402	0.00402	CbGpPWpGaD
Irinotecan—CYP3A7—Biological oxidations—COMT—conduct disorder	0.00398	0.00398	CbGpPWpGaD
Irinotecan—CYP3A7—Biological oxidations—MAOA—conduct disorder	0.00395	0.00395	CbGpPWpGaD
Irinotecan—BCHE—Transmission across Chemical Synapses—COMT—conduct disorder	0.00394	0.00394	CbGpPWpGaD
Irinotecan—CYP3A7—Metapathway biotransformation—COMT—conduct disorder	0.00392	0.00392	CbGpPWpGaD
Irinotecan—BCHE—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00391	0.00391	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00388	0.00388	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00378	0.00378	CbGpPWpGaD
Irinotecan—ABCG2—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.0037	0.0037	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00368	0.00368	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of proteins—CGA—conduct disorder	0.00366	0.00366	CbGpPWpGaD
Irinotecan—ABCC2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.0035	0.0035	CbGpPWpGaD
Irinotecan—ABCC1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00346	0.00346	CbGpPWpGaD
Irinotecan—ACHE—Neuronal System—COMT—conduct disorder	0.00338	0.00338	CbGpPWpGaD
Irinotecan—ACHE—Neuronal System—MAOA—conduct disorder	0.00336	0.00336	CbGpPWpGaD
Irinotecan—SLCO1B1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00329	0.00329	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of proteins—CGA—conduct disorder	0.00327	0.00327	CbGpPWpGaD
Irinotecan—ABCG2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00304	0.00304	CbGpPWpGaD
Irinotecan—BCHE—Neuronal System—COMT—conduct disorder	0.00302	0.00302	CbGpPWpGaD
Irinotecan—BCHE—Neuronal System—MAOA—conduct disorder	0.003	0.003	CbGpPWpGaD
Irinotecan—CYP2B6—Biological oxidations—COMT—conduct disorder	0.00294	0.00294	CbGpPWpGaD
Irinotecan—CYP2B6—Biological oxidations—MAOA—conduct disorder	0.00292	0.00292	CbGpPWpGaD
Irinotecan—CYP2B6—Metapathway biotransformation—COMT—conduct disorder	0.0029	0.0029	CbGpPWpGaD
Irinotecan—UGT1A9—PPARA activates gene expression—EP300—conduct disorder	0.0029	0.0029	CbGpPWpGaD
Irinotecan—CYP3A5—Biological oxidations—COMT—conduct disorder	0.00287	0.00287	CbGpPWpGaD
Irinotecan—CYP3A5—Biological oxidations—MAOA—conduct disorder	0.00285	0.00285	CbGpPWpGaD
Irinotecan—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—conduct disorder	0.00284	0.00284	CbGpPWpGaD
Irinotecan—CYP3A5—Metapathway biotransformation—COMT—conduct disorder	0.00283	0.00283	CbGpPWpGaD
Irinotecan—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.0025	0.0025	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—CGA—conduct disorder	0.0024	0.0024	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00211	0.00211	CbGpPWpGaD
Irinotecan—ABCB1—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.002	0.002	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.00196	0.00196	CbGpPWpGaD
Irinotecan—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—conduct disorder	0.00195	0.00195	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—CGA—conduct disorder	0.00189	0.00189	CbGpPWpGaD
Irinotecan—ALB—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00188	0.00188	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—CGA—conduct disorder	0.00179	0.00179	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—CGA—conduct disorder	0.00179	0.00179	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—CGA—conduct disorder	0.00173	0.00173	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—CGA—conduct disorder	0.00168	0.00168	CbGpPWpGaD
Irinotecan—ABCB1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00164	0.00164	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—CGA—conduct disorder	0.00164	0.00164	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—CGA—conduct disorder	0.00152	0.00152	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—CGA—conduct disorder	0.00151	0.00151	CbGpPWpGaD
Irinotecan—CYP3A4—Biological oxidations—COMT—conduct disorder	0.00134	0.00134	CbGpPWpGaD
Irinotecan—CYP3A4—Biological oxidations—MAOA—conduct disorder	0.00133	0.00133	CbGpPWpGaD
Irinotecan—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	0.00132	0.00132	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—CGA—conduct disorder	0.00111	0.00111	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—CGA—conduct disorder	0.00109	0.00109	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—COMT—conduct disorder	0.00108	0.00108	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—MAOA—conduct disorder	0.00107	0.00107	CbGpPWpGaD
Irinotecan—ALB—Metabolism—CGA—conduct disorder	0.000938	0.000938	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.000855	0.000855	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—COMT—conduct disorder	0.000852	0.000852	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—MAOA—conduct disorder	0.000846	0.000846	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CGA—conduct disorder	0.000821	0.000821	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.00082	0.00082	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—COMT—conduct disorder	0.000808	0.000808	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—COMT—conduct disorder	0.000808	0.000808	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—MAOA—conduct disorder	0.000803	0.000803	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—MAOA—conduct disorder	0.000803	0.000803	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—COMT—conduct disorder	0.000779	0.000779	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000778	0.000778	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—MAOA—conduct disorder	0.000774	0.000774	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—COMT—conduct disorder	0.00076	0.00076	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—MAOA—conduct disorder	0.000755	0.000755	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000751	0.000751	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—COMT—conduct disorder	0.000741	0.000741	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—MAOA—conduct disorder	0.000735	0.000735	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000732	0.000732	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000713	0.000713	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—COMT—conduct disorder	0.000686	0.000686	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—MAOA—conduct disorder	0.000681	0.000681	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—COMT—conduct disorder	0.00068	0.00068	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—MAOA—conduct disorder	0.000675	0.000675	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CGA—conduct disorder	0.000506	0.000506	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—COMT—conduct disorder	0.000503	0.000503	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—MAOA—conduct disorder	0.000499	0.000499	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—COMT—conduct disorder	0.000491	0.000491	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—MAOA—conduct disorder	0.000488	0.000488	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—EP300—conduct disorder	0.000464	0.000464	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—EP300—conduct disorder	0.000448	0.000448	CbGpPWpGaD
Irinotecan—ALB—Metabolism—COMT—conduct disorder	0.000423	0.000423	CbGpPWpGaD
Irinotecan—ALB—Metabolism—MAOA—conduct disorder	0.00042	0.00042	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000408	0.000408	CbGpPWpGaD
Irinotecan—ABCC1—Disease—EP300—conduct disorder	0.000399	0.000399	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—COMT—conduct disorder	0.000371	0.000371	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—MAOA—conduct disorder	0.000368	0.000368	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—EP300—conduct disorder	0.000365	0.000365	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—EP300—conduct disorder	0.000347	0.000347	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—EP300—conduct disorder	0.000347	0.000347	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—EP300—conduct disorder	0.000334	0.000334	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—EP300—conduct disorder	0.000326	0.000326	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—EP300—conduct disorder	0.000318	0.000318	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—EP300—conduct disorder	0.000294	0.000294	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—EP300—conduct disorder	0.000292	0.000292	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—COMT—conduct disorder	0.000228	0.000228	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—MAOA—conduct disorder	0.000227	0.000227	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—EP300—conduct disorder	0.000216	0.000216	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—EP300—conduct disorder	0.000211	0.000211	CbGpPWpGaD
Irinotecan—ALB—Metabolism—EP300—conduct disorder	0.000181	0.000181	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—EP300—conduct disorder	0.000159	0.000159	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—EP300—conduct disorder	9.8e-05	9.8e-05	CbGpPWpGaD
